Epidemiology of bladder cancer in 2023: a systematic review of risk factors I Jubber, S Ong, L Bukavina, PC Black, E Compérat, AM Kamat, ... European urology, 2023 | 91 | 2023 |
Benign prostate disorders N Lawrentschuk, G Ptasznik, S Ong | 35 | 2015 |
Role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer D Bagguley, S Ong, JP Buteau, S Koschel, N Dhiantravan, MS Hofman, ... Future Oncology 17 (17), 2225-2241, 2021 | 24 | 2021 |
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review S Ong, J O’Brien, E Medhurst, N Lawrentschuk, D Murphy, A Azad Translational Andrology and Urology 10 (10), 3918, 2021 | 17 | 2021 |
Irreversible electroporation for prostate cancer S Ong, M Leonardo, T Chengodu, D Bagguley, N Lawrentschuk Life 11 (6), 490, 2021 | 15 | 2021 |
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus? S Ong, K Chen, J Grummet, J Yaxley, MJ Scheltema, P Stricker, KJ Tay, ... BJU international 131 (1), 20-31, 2023 | 14 | 2023 |
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis S Huang, S Ong, D McKenzie, A Mirabelli, DC Chen, T Chengodu, ... Prostate Cancer and Prostatic Diseases, 1-11, 2023 | 10 | 2023 |
Understanding the diagnosis of prostate cancer XRS Ong, D Bagguley, JW Yaxley, AA Azad, DG Murphy, N Lawrentschuk Medical Journal of Australia 213 (9), 424-429, 2020 | 10 | 2020 |
3D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review J Coles-Black, S Ong, J Teh, P Kearns, J Ischia, D Bolton, ... Journal of Robotic Surgery 17 (1), 1-10, 2023 | 8 | 2023 |
Unlocking the DOOR–how to design, apply, analyse, and interpret desirability of outcome ranking (DOOR) endpoints in infectious diseases clinical trials SWX Ong, N Petersiel, MR Loewenthal, N Daneman, SYC Tong, JS Davis Clinical Microbiology and Infection, 2023 | 7 | 2023 |
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 XR Sean Ong, B Condon, D Bagguley, N Lawrentschuk, A Azad, ... Future Oncology 16 (20), 1409-1411, 2020 | 6 | 2020 |
Biomarkers accurately inform treatment decisions in localised prostate cancer K Chen, S Ong, N Lawrentschuk European Urology Focus 8 (3), 643-645, 2022 | 4 | 2022 |
Evaluating the use of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the workup of Staphylococcus aureus bacteraemia: a cost-utility analysis SWX Ong, A Zhabokritsky, N Daneman, SYC Tong, HC Wijeysundera Clinical Microbiology and Infection 29 (11), 1417-1423, 2023 | 3 | 2023 |
Are we enrolling the right patients? A Scoping review of external validity and Generalizability of clinical trials in bloodstream infections SWX Ong, SYC Tong, N Daneman Clinical Microbiology and Infection, 2023 | 3 | 2023 |
The clinical applications of serum and urinary biomarkers in prostate cancer R Eapen, P Lonergan, D Bagguley, S Ong, B Condon, N Lawrentschuck, ... Société Internationale d'Urologie Journal 1 (1), 23-29, 2020 | 3 | 2020 |
‘Evaluating the use of 18F-FDG PET/CT in the workup of Staphylococcus aureus bacteraemia: a cost-utility analysis’—Author's reply SWX Ong, A Zhabokritsky, N Daneman, SYC Tong, HC Wijeysundera Clinical Microbiology and Infection 29 (11), 1459-1460, 2023 | 2 | 2023 |
A Systematic Review of the Variability in Performing and Reporting Intraprostatic Prostate-specific Membrane Antigen Positron Emission Tomography in Primary Staging Studies G Ptasznik, D Moon, J Buteau, BD Kelly, S Ong, DG Murphy, M Page, ... European Urology Open Science 50, 91-105, 2023 | 2 | 2023 |
The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer D Bagguley, L Harewood, D McKenzie, G Ptasznik, S Ong, T Chengodu, ... BJU international 133, 27-36, 2024 | 1 | 2024 |
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters A Rouers, N Wong, YS Goh, A Torres‐Ruesta, MZ Tay, ZW Chang, ... Journal of Medical Virology 95 (1), e28258, 2023 | 1 | 2023 |
Long Term follow-up of men having a PSMA PET-CT for biochemical progression of prostate cancer-Is a negative scan prognostic? S Ong, C Pascoe, Z Ballock, S Sengupta, D Murphy, N Lawrentschuk BJU INTERNATIONAL 129, 155-155, 2022 | 1 | 2022 |